Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes

Airas, 1993, Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium, J. Immunol., 151, 4228, 10.4049/jimmunol.151.8.4228 Alam, 2009, CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice, J. Infect. Dis., 199, 494, 10.1086/596205 Apasov, 2000, Study of A(2A) adenosine receptor gene deficient mice reveals that adenosine analogue CGS 21680 possesses no A(2A) receptor-unrelated lymphotoxicity, Br. J. Pharmacol., 131, 43, 10.1038/sj.bjp.0703532 Armstrong, 2001, Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice, Biochem. J., 354, 123, 10.1042/bj3540123 Behdad, 2009, Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice, Purinergic Signal, 5, 335, 10.1007/s11302-009-9158-y Borsellino, 2007, Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression, Blood, 110, 1225, 10.1182/blood-2006-12-064527 Corcione, 2006, Human mesenchymal stem cells modulate B-cell functions, Blood, 107, 367, 10.1182/blood-2005-07-2657 Deaglio, 2007, Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, J. Exp. Med., 204, 1257, 10.1084/jem.20062512 Di Nicola, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, 3838, 10.1182/blood.V99.10.3838 Di, 2008, Mesenchymal cells recruit and regulate T regulatory cells, Exp. Hematol., 36, 309, 10.1016/j.exphem.2007.11.007 Dong, 1996, Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response, J. Immunol., 156, 1349, 10.4049/jimmunol.156.4.1349 Dwyer, 2007, CD39 and control of cellular immune responses, Purinergic Signal, 3, 171, 10.1007/s11302-006-9050-y Eltzschig, 2003, Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors, J. Exp. Med., 198, 783, 10.1084/jem.20030891 Fletcher, 2009, CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis, J. Immunol., 183, 7602, 10.4049/jimmunol.0901881 Franco, 1998, Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes, Immunol. Rev., 161, 27, 10.1111/j.1600-065X.1998.tb01569.x Fredholm, 2003, Pharmacology of adenosine A2A receptors and therapeutic applications, Curr. Top. Med. Chem., 3, 413, 10.2174/1568026033392200 Friedenstein, 1966, Osteogenesis in transplants of bone marrow cells, J. Embryol. Exp. Morphol., 16, 381 Gessi, 2007, Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype, J. Cell. Physiol., 211, 826, 10.1002/jcp.20994 Huang, 1997, Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion, Blood, 90, 1600, 10.1182/blood.V90.4.1600 Kameoka, 1993, Direct association of adenosine deaminase with a T cell activation antigen, CD26, Science, 261, 466, 10.1126/science.8101391 Kobie, 2006, T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine, J. Immunol., 177, 6780, 10.4049/jimmunol.177.10.6780 Koshiba, 1997, Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells, J. Biol. Chem., 272, 25881, 10.1074/jbc.272.41.25881 Krampera, 2003, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, 101, 3722, 10.1182/blood-2002-07-2104 Lappas, 2005, A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells, J. Immunol., 174, 1073, 10.4049/jimmunol.174.2.1073 Lappas, 2010, Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation, J. Leukoc. Biol., 87, 345, 10.1189/jlb.0609388 Le Blanc, 2008, Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study, Lancet, 371, 1579, 10.1016/S0140-6736(08)60690-X Le Blanc, 2004, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7 Maccario, 2005, Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype, Haematologica, 90, 516 Mandapathil, 2010, Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells, J. Biol. Chem., 285, 7176, 10.1074/jbc.M109.047423 Morimoto, 1998, The structure and function of CD26 in the T-cell immune response, Immunol. Rev., 161, 55, 10.1111/j.1600-065X.1998.tb01571.x Ohta, 2001, Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage, Nature, 414, 916, 10.1038/414916a Pfaffl, 2001, Tissue-specific expression pattern of estrogen receptors (ER): quantification of ER alpha and ER beta mRNA with real-time RT-PCR, APMIS, 109, 345, 10.1034/j.1600-0463.2001.090503.x Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 Prevosto, 2007, Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell–lymphocyte interaction, Haematologica, 92, 881, 10.3324/haematol.11240 Rasmusson, 2005, Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms, Exp. Cell Res., 305, 33, 10.1016/j.yexcr.2004.12.013 Resta, 1998, Ecto-enzyme and signaling functions of lymphocyte CD73, Immunol. Rev., 161, 95, 10.1111/j.1600-065X.1998.tb01574.x Robinson, 1991, Phosphatidylinositol membrane anchors and T-cell activation, Immunol. Today, 12, 35, 10.1016/0167-5699(91)90110-F Thomson, 1990, Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73), Tissue Antigens, 35, 9, 10.1111/j.1399-0039.1990.tb01750.x Sattler, 2010, Inhibition of T cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39/CD73 coexpression and adenosine generation, Cell Transplant. Schmitt, 2009, Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production, Transplantation, 88, 411, 10.1097/TP.0b013e3181aed927 Silva, 2003, The profile of gene expression of human marrow mesenchymal stem cells, Stem Cells, 21, 661, 10.1634/stemcells.21-6-661 Sitkovsky, 2005, Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors, Nat. Rev. Immunol., 5, 712, 10.1038/nri1685 Sitkovsky, 2005, The ‘danger’ sensors that STOP the immune response: the A2 adenosine receptors, Trends Immunol., 26, 299, 10.1016/j.it.2005.04.004 Sitkovsky, 2004, Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors, Annu. Rev. Immunol., 22, 657, 10.1146/annurev.immunol.22.012703.104731 Spaggiari, 2006, Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation, Blood, 107, 1484, 10.1182/blood-2005-07-2775 Thiel, 2003, The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases, Microbes Infect., 5, 515, 10.1016/S1286-4579(03)00068-6 Tse, 2003, Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation, Transplantation, 75, 389, 10.1097/01.TP.0000045055.63901.A9 Valerio, 2009, Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors, 2009, 158, 558 Zimmermann, 1992, 5′-Nucleotidase: molecular structure and functional aspects, Biochem. J., 285, 345, 10.1042/bj2850345